Parkinson's Disease

Because of the side effects of levodopa use, people diagnosed with Parkinson’s often choose to delay treatment with levodopa and start with other approved therapies. Typically, the first step is to start with medications that mimic levodopa, like Pramipexole, or medications that help increase natural dopamine levels, like Rasagiline. This clinical trial (phase 3) will research whether combining those two therapies at lower doses will result in good therapeutic effect, with fewer side effects. A previous clinical trial (Phase IIb) of the combination therapy showed positive results.

If you would like to speak to someone regarding this trial first check to see if you are eligible below. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional eligiblity questions, and you will be able to ask any additional questions you may have about this clinical trial.

White brain outline

Check eligibility?

Study details

Eligibility requirements

Participants must:

  • Be at least 35 to 80 years old
  • Have a diagnosis of Parkinson's Disease less than 3 years ago

Participants must not:

  • Have taken any Parkinson's Disease medications for longer than 4 weeks
  • Be enrolled in any other clinical trials
  • Be on dialysis

If you would like to speak to someone regarding this trial first check above to see if you are eligible. If it seems that you are eligible to take part, you will be contacted by phone so we can ask you additional eligiblity questions, and you will be able to ask any additional questions you may have about this clinical trial.